Home Your basket
• Cervical liposuction: A r...
   Price 10.50 €
• Teratoma of the parotid g...
   Price 5.50 €
• Side-to-end hypoglossal-f...
   Price 10.50 €
• Tinnitus: first symptom o...
   Price 5.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• Detection and role of hum...
   Price 14.00 €
• Central auditory processi...
   Price 10.50 €
• Changing patterns of bucc...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• "Endolymphatic" cochleo-v...
   Price 10.50 €
• Otoplasty for prominent e...
   Price 8.50 €
• Innovations in interventi...
   Price 15.00 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• Facial dissection applied...
   Price 14.00 €
• Importance of swallowing ...
   Price 10.50 €
• Anatomic evaluation of th...
   Price 10.50 €
• Brain stem cavernous angi...
   Price 8.50 €
• Primary sub-mandibular gl...
   Price 8.50 €
• Bilateral and recurrent f...
   Price 5.50 €
• Giant metastasis invading...
   Price 5.50 €
• Assumptions in surgical t...
   Price 8.50 €
• Assessing efficacy of voi...
   Price 5.50 €
• Tuberculosis of the laryn...
   Price 5.50 €
• Aesthetic profiloplasty: ...
   Price 10.50 €
• Cholesterol granuloma of ...
   Price 8.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Synovial sarcoma of the h...
   Price 5.50 €
• Salivary gland choristoma...
   Price 5.50 €
• New trends in rhinoplasty...
   Price 10.50 €
• «Mini-rhinoplasty»...
   Price 10.50 €
• Otolaryngological aspects...
   Price 8.50 €
• Cholesteatoma behind a no...
   Price 10.50 €
• What is the effect of diz...
   Price 10.50 €
• Spontaneous cholesteatoma...
   Price 8.50 €
• Augmentation of the abdom...
   Price 10.50 €

Total Order 311.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2000 o

LARYNGOLOGY

Evaluation of the primary tumour and the metastatic lymph node with or without extracapsular spread by means of argyrophillic nucleolar regions (AgNOR)


Authors : C. Bilgen, S. Sarioglu, K. Ceryan (Izmir)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,3:155-159.

Article published in english
Downloadable PDF document english



Summary : Though TNM staging is the most popular clinical system for defining the prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC), different clinical trials of the tumours with the same TNM stage have caused doubts about this system. Extra Capsular Spread (ECS) in a metastatic lymph node is one of the recently defined prognostic factors in HNSCC. The hypothesis of this study was to assess the relationship between the primary tumour of laryngeal and oral cavity squamous cell carcinoma and the metastatic lymph nodes with and without ECS. The argyrophillic Nucleolar Organiser Regions (AgNOR) count was used as an index of the grade of malignancy of the neoplastic tissue. As a result, significantly higher AgNOR counts were obtained in the metastatic lymph nodes with ECS than in the primary tumours, while the lowest AgNOR counts were found in the metastatic lymph nodes without ECS. However, when primary tumours of the metastatic lymph nodes with ECS and the primary tumours of the metastatic lymph nodes without ECS were compared, no significant difference was found.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE